CTLA4 and neoplasm: This inhibitory effect might potentially occur through the interaction between CTLA-4 expressed by the tumor cells and B7 ligands expressed by the tumor microenvironment cells including the antigen presenting cells (APC), such as dendritic cells (DCs), or antitumor activated T cells.